Abstract
The current study investigates the role of regulatory T (Treg) cells in the pathogenesis of ocular attack in patients with Behcet’s disease (BD). Nineteen BD patients with ocular complications (BDo), including 11 BD patients with ocular attack (BDa) and eight BD patients with inactive ocular complications (BDi), were studied. Four BD patients without ocular complications (BDwo) were also evaluated as controls. All patients were prospectively followed by our outpatient clinic between autumn 2004 and spring 2005. CD4+ CD25+bright T cells (Treg cells) from peripheral blood were measured by flow cytometry. The percentages of Treg cells in CD4+ T cells from BDo were significantly decreased before ocular attack compared with those after ocular attack. Moreover, surprisingly, these levels before attack were significantly lower than normal level, whereas the percentages of Treg cells in both BDi and BDwo patients were normal. Treg cells were significantly decreased in BDa before active ocular attack. These findings suggest that Treg cells play an important role in ocular attack in BD patients. In addition, decreased percentages of Treg cells may be a predictive marker of ocular attack in BD patients allowing treatment of BD patients before an ocular attack.
Similar content being viewed by others
Abbreviations
- BD:
-
Behcet’s disease
- Treg:
-
regulatory T
References
Sakane T. Behcet’s disease. N Eng J Med. 1999;341:1284–91.
Nanke Y, Kotake S, Tateishi M, Yamanaka H, Kamatani N. Synovial histology in three Behcet’s disease patients with orthopedic surgery. Clin Exp Rheumatol. 2002;20:35–44.
Nanke Y, Kotake S, Ogasawara K et al. Raised plasma adrenomedullin level in Behcet’s disease patients. Mod Rheumatol. 2003;13:139–42.
Sakaguchi S, Sakaguchi N, Shimizu J. Immunological tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18–32.
Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes J. Clin Investig. 2002;109:131–40.
Amelsfort J, Jacvobs K, Bijlsma J, Lafeber F, Taams L. CD4+ CD25+ regulatory T cells in rheumatoid arthritis. Difference in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004;50:2775–85.
Cao D. Isolation and functional characterization of regulatory CD25brightCD4 T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215–23.
Crispin JC, Martinez A, Varela JA. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2003;21:273–6.
Gottenberg JE, Lavie F, Abbed K et al. CD4+ CD25+ high regulatory T cells are not impaired in patients with primary Sjögren’s syndrome. J Autoimmun. 2005;24:235–42.
International Study Group for Behcet’s Disease: criteria for diagnosis of Behcet’s disease. Lancet. 1999;335:1078–80.
Behcet’s Disease Research Committee of Japan. Behcet’s disease: a guide to diagnosis of Behcet’s disease. Jpn J Ophthalmol. 1974;18:291–4.
Jiao Z, Wang W, Jia R et al. Accumulation of FoxP3-expressing CD4(+)CD25(+) T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol. 2007;36:428–33.
Grajewski R, Silver P, Agarwal RK et al. Endogenous IRBP can be dispensable for generation of natural CD4+ CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. JEM. 2006;203:851–6.
Ehrenstein MR, Evans JG, Singh A et al. Compromised function of regulatory T cells in Rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med. 2004;200:277–85.
Sarin A, Conan-Cibotti M, Henkart P. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol. 1995;155:3716–8.
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Fox P3. Science. 2003;299:1057–61.
Allan SE, Crome SQ, Crellin NK et al. Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol. 2007;19:345–54.
Hamzaoui K, Hamzaoui A, Houman H. CD4+ CD25+regulatory T cells in patients with Behcet’s disease. Clin Exp Rheumatol. 2006;24:S71–8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nanke, Y., Kotake, S., Goto, M. et al. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet’s disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol 18, 354–358 (2008). https://doi.org/10.1007/s10165-008-0064-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-008-0064-x